Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Inverness, Medarex, Oxford Genome Sciences Ltd. deal

Oxford Genome received access to MEDX's UltiMAb Human Antibody Development System to generate human therapeutic

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE